Effect of combination therapy (Ang II antagonist, valsartan and a calcium channel blocker) in a hypertensive model of diabetic nephropathy

被引：0
|
作者：
Allen, T
Davis, B
de Gasparo, M
Cooper, M
机构：
[1] Univ Melbourne, Dept Med, Heidelberg, Vic, Australia
[2] Novartis Pharmaceut, Basel, Switzerland
来源：
JOURNAL OF HYPERTENSION | 2000年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S137 / S137
页数：1
相关论文
共 50 条
  • [21] COMBINED EFFECTS OF ANGIOTENSIN II RECEPTOR ANTAGONIST AND CALCIUM CHANNEL BLOCKER IN HYPERTENSIVE PATIENTS WITH TYPE 2 DIABETES
    Yokoi, T.
    Nakade, S.
    Masaki, H.
    Komiyama, Y.
    Masuda, M.
    Yoshika, M.
    Tsukaguchi, H.
    Takahashi, H.
    JOURNAL OF HYPERTENSION, 2010, 28 : E297 - E298
  • [22] Efficacy and Safety of Calcium Channel Blocker/Diuretics Combination Therapy in Hypertensive Patients: A Meta-Analysis
    Rimoldi, Stefano F.
    Messerli, Franz H.
    Chavez, Patricia
    Stefanini, Giulio G.
    Scherrer, Urs
    JOURNAL OF CLINICAL HYPERTENSION, 2015, 17 (03): : 193 - 199
  • [23] Effect of the angiotensin II antagonist valsartan on sexual function in hypertensive men
    Düsing, R
    BLOOD PRESSURE, 2003, 12 : 29 - 34
  • [24] Effects of an ACE inhibitor combined with a calcium channel blocker on progression of diabetic nephropathy
    Bakris, G
    White, D
    JOURNAL OF HUMAN HYPERTENSION, 1997, 11 (01) : 35 - 38
  • [25] Effects of an ACE inhibitor combined with a calcium channel blocker on progression of diabetic nephropathy
    G Bakris
    D White
    Journal of Human Hypertension, 1997, 11 : 35 - 38
  • [26] Better renoprotective effect of angiotensin II antagonist compared to dihydropyridine calcium channel blocker in childhood
    Gartenmann, AC
    Fossali, E
    von Vigier, RO
    Simonetti, GD
    Schmidtko, J
    Edefonti, A
    Bianchetti, MG
    KIDNEY INTERNATIONAL, 2003, 64 (04) : 1450 - 1454
  • [27] Angiotensen II receptor blocker and calcium channel blocker combination therapy is cost-effective compared to mono therapy in treating hypertensive patients. Pharmacoeconomic evaluation by Monte Carlo simulation model in Japan
    Saito, Ikuo
    Kobayashi, Makoto
    Matsushita, Yasuyuki
    Kawasugi, Kaname
    Sarutas, Takao
    JOURNAL OF HYPERTENSION, 2006, 24 : 199 - 199
  • [28] COMBINED ANTIHYPERTENSIVE THERAPY WITH ANGIOTENSIN II RECEPTOR ANTAGONIST AND CALCIUM CHANNEL BLOCKER IN PATIENTS WITH METABOLIC SYNDROME
    Uzokov, Jamol
    Alyavi, Anis
    Hojiev, Sarvar
    Yaxshilikov, Davron
    Dadaev, Sarvar
    JOURNAL OF HYPERTENSION, 2016, 34 : E447 - E447
  • [29] A DIFFERENT DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKER IN HYPERTENSIVE PATIENTS WHO DEVELOPED PEDAL EDEMA ON DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKER THERAPY
    Yuksel, A.
    Karagoz, A.
    Ucar, O.
    Aydogdu, S.
    Celik, A.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 163 : S126 - S127
  • [30] Effect of lipoic acid combination with valsartan on diabetic nephropathy and associated adverse reactions
    Wang, Minqin
    Luo, Jiaying
    Xue, Jisu
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2024, 23 (07) : 1127 - 1133
12345